当前位置:首页 - 行情中心 - 津药药业(600488) - 财务分析 - 现金流量表

津药药业

(600488)

  

流通市值:46.19亿  总市值:46.19亿
流通股本:10.92亿   总股本:10.92亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,798,274,725.191,218,663,367.77588,032,410.833,111,885,744.94
  收到的税费返还89,352,421.9253,204,040.8125,352,337.88130,545,239.24
  收到其他与经营活动有关的现金43,372,316.526,218,774.8713,517,583.7367,824,902.1
  经营活动现金流入小计1,930,999,463.611,298,086,183.45626,902,332.443,310,255,886.28
  购买商品、接受劳务支付的现金1,073,145,869.5692,847,075.55320,398,896.31,737,546,632.67
  支付给职工以及为职工支付的现金448,904,874.83325,753,338.18200,652,166.69532,093,280.09
  支付的各项税费167,782,011.33101,416,404.6459,570,296.41270,400,851.45
  支付其他与经营活动有关的现金207,779,046.99157,868,786.0656,783,004.67200,843,324.17
  经营活动现金流出小计1,897,611,802.651,277,885,604.43637,404,364.072,740,884,088.38
  经营活动产生的现金流量净额33,387,660.9620,200,579.02-10,502,031.63569,371,797.9
二、投资活动产生的现金流量:
  取得投资收益收到的现金1,685,119.851,685,119.85--
  处置固定资产、无形资产和其他长期资产收回的现金净额6,800,0000-1,953,600.98
  投资活动现金流入的平衡项目00-0
  投资活动现金流入小计8,485,119.851,685,119.85-1,953,600.98
  购建固定资产、无形资产和其他长期资产支付的现金42,308,678.9124,821,271.0811,207,769.4977,740,241.43
  投资支付的现金20,400,000---
  支付其他与投资活动有关的现金000400,000
  投资活动现金流出小计62,708,678.9124,821,271.0811,207,769.4978,140,241.43
  投资活动产生的现金流量净额-54,223,559.06-23,136,151.23-11,207,769.49-76,186,640.45
三、筹资活动产生的现金流量:
  取得借款收到的现金311,129,071.2311,129,071.2217,124,391.02780,489,561.6
  筹资活动现金流入小计311,129,071.2311,129,071.2217,124,391.02780,489,561.6
  偿还债务支付的现金123,394,561.6113,394,561.680,000,0001,198,691,554.17
  分配股利、利润或偿付利息支付的现金122,069,631.57117,020,264.245,120,325.89164,372,792.99
  其中:子公司支付给少数股东的股利、利润---41,002,248.42
  支付其他与筹资活动有关的现金37,068,997.2837,025,528.793,043,027.234,942,145.49
  筹资活动现金流出小计282,533,190.45267,440,354.6388,163,353.091,398,006,492.65
  筹资活动产生的现金流量净额28,595,880.7543,688,716.57128,961,037.93-617,516,931.05
四、汇率变动对现金及现金等价物的影响1,615,246.072,042,172.74983,500.5215,891,129.11
五、现金及现金等价物净增加额9,375,228.7242,795,317.1108,234,737.33-108,440,644.49
  加:期初现金及现金等价物余额594,566,597.63594,566,597.63594,566,597.63703,007,242.12
  期末现金及现金等价物余额603,941,826.35637,361,914.73702,801,334.96594,566,597.63
补充资料:
  净利润-84,377,354.25-208,212,548.19
  资产减值准备-5,643,012.22-7,977,073.18
  固定资产和投资性房地产折旧-127,339,068.24-253,575,858.6
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-127,339,068.24-253,575,858.6
  无形资产摊销-23,343,618.15-43,099,941.6
  长期待摊费用摊销-0-0
  处置固定资产、无形资产和其他长期资产的损失-9,235.51-33,485.38
  固定资产报废损失-0-62,268.91
  公允价值变动损失-0-0
  财务费用-9,817,134.29-15,147,207.67
  投资损失--2,465,706.88-9,091,758.55
  递延所得税-673,402.57-11,574,632.01
  其中:递延所得税资产减少-1,257,424.27-12,748,582.58
    递延所得税负债增加--584,021.7--1,173,950.57
  存货的减少--39,288,172.97-94,997,232.2
  经营性应收项目的减少--234,385,286.1-77,306,730.04
  经营性应付项目的增加-44,560,417.86--152,148,563.32
  其他-0-0
  债务转为资本-0-0
  一年内到期的可转换公司债券-0-0
  融资租入固定资产-0-0
  现金的期末余额-637,361,914.73-594,566,597.63
  减:现金的期初余额-594,566,597.63-703,007,242.12
  加:现金等价物的期末余额-0-0
  减:现金等价物的期初余额-0-0
  现金及现金等价物的净增加额-42,795,317.1--108,440,644.49
公告日期2025-10-292025-08-232025-04-292025-03-27
审计意见(境内)标准无保留意见
TOP↑